@article {Kase2020.09.16.20191528, author = {Kerstin Kase and Agata Skrzat-Klapaczy{\'n}ska and Anna Vassilenko and Arjan Harxhi and Botond Lakatos and Gordana Dragovi{\'c} Luki{\'c} and David Jilich and Antonija Verhaz and Nina Yancheva and Florentina Dumitrescu and Raimonda Matulionyte and Andrzej Horban and Justyna D. Kowalska}, title = {The case series of 34 patients with COVID-19 diagnosed with HIV infection from Central and Eastern European Countries {\textendash} Euroguidelines in Central and Eastern Europe Network Group data}, elocation-id = {2020.09.16.20191528}, year = {2020}, doi = {10.1101/2020.09.16.20191528}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background A novel coronavirus (SARS-CoV-2) causing coronavirus disease (COVID-19) was detected at the end of 2019 in China. There are many COVID-19 studies in progress however, little is known about the course of COVID-19 in people living with HIV (PLWH). The aim of our study was to describe epidemiology and clinical characteristics of PLWH diagnosed with COVID-19 reported form Central and Eastern European Countries.Methods On-line survey was sent to Euroguidelines in Central and Eastern Europe (ECEE) Network Group. Analysis included all confirmed COVID-19 cases between March 11 and June 26 2020 among PLWH in 12 countries: Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Czech Republic, Estonia, Hungary, Lithuania, Poland, Romania, Russia, and Serbia.Results In total 34 cases were reported. The mean age of those patients was 42.7 years (IQR = 35.8-48.5) and most of the patients were male (70.6\% vs 29.4\%). The mean CD4+ T-cell count prior COVID-19 diagnosis was 558 cells/mm3 (IQR = 312-719) and HIV RNA viral load (VL) was undetectable in 18 of 34 (53\%) cases, the data about most recent HIV RNA VL was not available in three cases (8,8\%). Comorbidities were observed in 19 (55.9\%) patients, mostly cardiovascular disease (27,8\%), and in 10 (29.4\%) patients had coinfection, mostly chronic hepatitis C (87.5\%). The clinical course of COVID-19 was asymptomatic in 4 (12\%) cases, mild disease without hospitalization was reported in 11 (32\%) cases. Stable patients with respiratory and/or systemic symptoms have been documented in 14 (41\%) cases; 5 (15\%) patients were clinically unstable with respiratory failure. Full recovery was reported in 31 (91\%) cases, two patients died. In one case the data was not available.Conclusion This study from 12 countries in Central and Eastern Europe region indicates no alarming signals of increased morbidity or mortality from COVID-19 among HIV-positive persons there is a need for further research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Bioethical Committee of the Medical University of Warsaw (Nr AKBE/155/2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available if needed}, URL = {https://www.medrxiv.org/content/early/2020/09/18/2020.09.16.20191528}, eprint = {https://www.medrxiv.org/content/early/2020/09/18/2020.09.16.20191528.full.pdf}, journal = {medRxiv} }